Sakuma, S., Sumida, M., Endo, H.Y., Kurita, A., Yamaguchi, A., Watanabe, T., Kohda, T., Tsukiyama, Y. and Fujimoto, Y. (2017) Curcumin Inhibits Adipogenesis Induced by Benzyl Butyl Phthalate in 3T3-L1 Cells. Toxicology and Applied Pharmacology, 329, 158-164. https://doi.org/10.1016/j.taap.2017.05.036

has been cited by the following article:

• TITLE: Curcumin Inhibits Adipogenesis Elicited by Clozapine in 3T3-L1 Cells

  AUTHORS: Satoru Sakuma, Maki Sumida, Asami Sakabe, Ayaka Nakamura, Chisato Noda, Kaho Tsujimoto, Maimi Kobayashi, Tomohiko Sano, Yohko Fujimoto, Tetsuya Kohda

  KEYWORDS: Clozapine, Curcumin, Adipocyte Differentiation, 3T3-L1 Cell, Atypical Antipsychotic Drug

  JOURNAL NAME: Food and Nutrition Sciences, Vol.9 No.5, May 24, 2018

  ABSTRACT: Although clozapine (CZP), which is used for schizophrenia treatment, causes weight gain, the mechanism remains unclear. We recently reported that the naturally occurring compound curcumin (CUR) suppresses adipogenesis in 3T3-L1 cells. The aims of the present study were to determine the mechanism by which CZP induces adipocyte differentiation of 3T3-L1 cells, and whether CUR reduces CZP-induced adipogenesis. We found that cells grown in the presence of CZP had significantly higher triacylglycerol levels, numbers of lipid-filled adipocytes, and mRNA expression levels of CCAAT-enhancer binding protein α (C/EBPα) and peroxisome proliferator-activated receptor γ (PPARγ) than those grown without CZP. Treatment with CZP plus CUR resulted in major reductions in these four parameters. These results suggest that CZP enhances adipogenesis in 3T3-L1 cells via the C/EBPα-PPARγ pathway and that by interrupting CZP’s effects, CUR might be a potent agent for preventing CZP-induced weight gain.